call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Companion Animal Pharmaceuticals Market
Inquire Before Buying Request for Sample

Companion Animal Pharmaceuticals Market

Home Healthcare And Pharmaceutical Companion Animal Pharmaceuticals Market

Companion Animal Pharmaceuticals Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Animal (Dogs, Cats, Horses); By Route of Administration (Oral, Injectable, Topical); By Product (Antibiotics, Anti-Inflammatory, Parasiticides, Vaccines); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: May 2023
  • Report ID: BWC23375
  • Available Format: PDF
  • Page: 400

Report Overview

Growing awareness about animal health and wellness, increasing pet ownership and humanization of pets, and adoption of advancements in veterinary healthcare technology are projected to propel the expansion of the global companion animal pharmaceuticals market during the forecast period between 2023 and 2029.

Global Companion Animal Pharmaceuticals Market - Industry Trends & Forecast Report, 2029

The global companion animal pharmaceuticals market size was estimated at USD 34.8 billion in 2022. During the forecast period between 2023 and 2029, the size of global companion animal pharmaceuticals market is projected to grow at a CAGR of 4.42% reaching a value of USD 45.12 billion by 2029. Major growth drivers for the global companion animal pharmaceuticals market include an increasing number of pet adoptions, the rising prevalence of pet diseases, and the growing awareness of the importance of pet health. Also, a surge in demand for pet insurance owing to the rising expenditure on animal health, escalating investments in research and development (R&D) for animal healthcare, and high rates of pet ownership across the globe are expected to further drive the global market during the period in analysis.

Companion Animal Pharmaceuticals Market

Global Companion Animal Pharmaceuticals Market – Overview

A companion animal differs from an assistive animal in that it does not receive any specific training to help a person with a disability. Instead, companion animals provide humans with companionship, entertainment, emotional support, and other functions that humans need from animals. Veterinarians who specialize in companion animals can perform a range of medical services, including treating injuries and illnesses, performing surgeries, administering vaccines, and prescribing medications. They are also responsible for euthanizing animals when necessary. The owners of companion animals are responsible for the animal's well-being, actions, and care. When choosing a companion animal, it is essential to consider the owner's lifestyle, budget, and ability to provide proper care throughout the animal's life. Animal health products, such as feeds, are the most commonly used products for animal healthcare, and this market includes pharmaceuticals and vaccines that improve the health and welfare of animals. Animals obtain nutrition from these products. In recent years, the number of people who own and spend money on companion animals has increased, and pet owners now spend more money per pet than in the past. Pet owners prioritize their pet's health and wellness and expect them to live healthy lifestyles.

Global Companion Animal Pharmaceuticals Market

Growth Drivers

Rising Awareness about Animal Health and Wellness

The rising awareness about animal health and wellness is driving the demand for companion animal pharmaceutical products. Pet owners are increasingly concerned about the health and well-being of their pets and are willing to spend more money on their care. It has led to a significant increase in demand for animal health products, including pharmaceuticals and vaccines. As pet ownership rates continue to rise worldwide, the market for companion animal pharmaceuticals is expected to grow. Pet owners are becoming more aware of the importance of preventative care for their pets, which includes regular check-ups, vaccinations, and treatments for common health issues. In addition, the increasing prevalence of chronic diseases in animals has also contributed to the growth of the market. Companion animal pharmaceuticals are used to treat a wide range of illnesses and conditions, including arthritis, cancer, diabetes, and heart disease. Furthermore, the growing trend of humanization of pets has also driven the demand for high-quality healthcare products and services for companion animals. Pet owners are increasingly treating their pets as members of the family, which has led to a higher demand for products and services that support their pets' health and well-being.

Restraints

Stringent Regulations and Lengthy Approval Processes for Animal Pharmaceutical Products

The growth of the companion animal pharmaceuticals market may be hindered by stringent regulations and lengthy approval processes for animal pharmaceutical products. Animal health products are subject to extensive testing and regulatory requirements before they can be approved for commercial use. The approval process for animal health products can be lengthy and costly, which can limit the availability of new and innovative treatments for pets. This can lead to a slow adoption of new animal health products and limit the growth of the companion animal pharmaceuticals market. Also, the costs associated with compliance with these regulations may lead to an increase in the prices of animal health products, which could further limit their accessibility to pet owners.

Impact of COVID-19 on Global Companion Animal Pharmaceuticals Market

COVID-19 pandemic had a dual impact on the global companion animal pharmaceuticals market. On the positive side, with lockdowns and social distancing measures in place, people were spending more time at home and turning to pets for comfort and companionship. It led to an increase in pet ownership and a surge in demand for animal healthcare products and services, including pharmaceuticals. However, on the negative side, the pandemic disrupted global supply chains and manufacturing activities, causing shortages of raw materials and finished products. It led to production delays and increased prices, which affected the profitability of the market players. Moreover, with the focus on human healthcare during the pandemic, veterinary care and services were deprioritized in some regions, leading to a decline in demand for companion animal pharmaceuticals. Despite these challenges, the overall impact of the pandemic on the companion animal pharmaceuticals market was relatively moderate, and the market is expected to recover as the situation normalizes. As people continue to value the companionship of their pets, the demand for animal healthcare products and services is expected to remain robust in the long term.

Global Companion Animal Pharmaceuticals Market

Segmental Coverage

Global Companion Animal Pharmaceuticals Market – By Animal

By animal, the global companion animal pharmaceuticals market is divided into Dogs, Cats, and Horses segments. The dogs segment held the highest share in the global companion animal pharmaceuticals market in 2020. According to Holland Insurance Company Pty. Ltd., India is experiencing an exponential growth in its pet dog population, driven by urbanization and millennials opting for dogs as pets. Also, the growing awareness of pet insurance and animal health importance is expected to boost market growth. On the other hand, the cats’ segment is projected to have the highest compound annual growth rate (CAGR) during the forecast period. Cats are becoming increasingly popular in certain countries like Canada and are preferred over dogs. Additionally, many companies are concentrating on expanding their product range for cats due to their greater susceptibility to diseases when compared to other pets.

Companion Animal Pharmaceuticals Market Share

Global Companion Animal Pharmaceuticals Market – By Route of Administration

Based on route of administration, the global companion animal pharmaceuticals market is divided into Oral, Injectable, and Topical segments. The oral segment holds the highest share in the global companion animal pharmaceuticals market. Oral medications are easy to administer and do not require a trained professional to give the medication, which makes it more convenient for pet owners. They are often available in a variety of forms, such as tablets, capsules, and liquids, which can be mixed with food or treats to make administration easier. This versatility allows for a wider range of medications to be given orally. Also, oral medications often have a longer shelf life and do not require refrigeration, which can make storage and distribution more efficient for manufacturers and suppliers.

Companion Animal Pharmaceuticals Market Size

Global Companion Animal Pharmaceuticals Market – By Product

Based on product, the global companion animal pharmaceuticals market is divided into Antibiotics, Anti-Inflammatory, Parasiticides, and Vaccines segments. The parasiticides segment holds the highest share in the global companion animal pharmaceuticals market, due to the high prevalence of parasitic infections in companion animals. Parasites, such as fleas, ticks, and heartworms, can cause serious health issues in pets and even transmit diseases to humans. As a result, pet owners are increasingly seeking preventive measures, such as the use of parasiticides, to protect their pets from these parasites. Additionally, the development of new and more effective parasiticide products is driving market growth in this segment. Meanwhile, the vaccines segment holds the second highest share in the global companion animal pharmaceuticals market because vaccines play a crucial role in preventing infectious diseases in companion animals. Vaccinations are an essential part of the animal healthcare routine, and regular vaccination schedules are recommended to prevent the spread of diseases. Moreover, the increasing awareness about the importance of vaccination among pet owners and the rising incidence of zoonotic diseases are also driving the demand for animal vaccines. The COVID-19 pandemic has also accelerated the demand for animal vaccines, with many pet owners seeking to protect their pets from the virus.

Global Companion Animal Pharmaceuticals Market – By Region

The in-depth research report on the global companion animal pharmaceuticals market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest market share, due to the increasing number of pets, greater pet expenditure, and the trend towards pet humanization. Also, there has been a significant increase in pets receiving medical care, particularly for cats, following the start of the COVID-19 pandemic. Meanwhile, the Asia-Pacific region is projected to record the fastest growth rate during the forecast period driven by the growing pet ownership and increased awareness of pet health and treatment. In India, insurance companies are offering pet insurance to meet the demand for quality and affordable pet care, and to cater to the needs of modern-day pet parents, particularly those owning rare and foreign breeds. It is expected to propel regional market growth, with major general insurance companies, such as Bajaj Allianz, New India Assurance, Vetina Pawtect, and Oriental Insurance, offering pet insurance in the country.

Competitive Landscape

Major players operating in the global companion animal pharmaceuticals market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Bayer AG, Virbac, Dechra Pharmaceuticals PLC, Vetoquinol SA, Ceva Santé Animale, Kindred Biosciences, Inc., Norbrook, IDEXX Laboratories, Inc., Animalcare Group plc, Neogen Corporation, and Heska Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In November 2022 - Virbac, a United States-based global leading provider of products focusing on companion animals, introduced a new joint supplement for dogs, MOVOFLEX, in Europe.

  • In January 2022 - Zoetis obtained approval from the US FDA for its chewable tablets, Simparica Trio (sarolaner, moxidectin, and pyrantel), which now includes a new label indication for the prevention of Borrelia burgdorferi infections in dogs.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Animal, Route of Administration, Product

Key Players

Zoetis Inc., Merck Animal Health, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Bayer AG, Virbac, Dechra Pharmaceuticals PLC, Vetoquinol SA, Ceva Santé Animale, Kindred Biosciences, Inc., Norbrook, IDEXX Laboratories, Inc., Animalcare Group plc, Neogen Corporation, Heska Corporation

 

By Animal

  • Dogs

  • Cats

  • Horses

By Route of Administration

  • Oral

  • Injectable

  • Topical

By Product

  • Antibiotics

  • Anti-Inflammatory

  • Parasiticides

  • Vaccines

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Companion Animal Pharmaceuticals Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing pet ownership and increasing humanization of pets
        2. Rising awareness about animal health and wellness
        3. Advancements in veterinary healthcare technology
      2. Restraints
        1. Stringent regulations and lengthy approval processes for animal pharmaceuticals
        2. High costs associated with veterinary drugs and treatments
      3. Opportunities
        1. Increasing demand for personalized and customized medicine for pets
        2. Rising trend of pet insurance, providing financial assistance for pet healthcare
      4. Challenges
        1. Concerns over the safety and efficacy of animal pharmaceuticals
        2. Lack of awareness and education about pet healthcare in certain regions
    3. Product Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Companion Animal Pharmaceuticals Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By Animal
        1. Dogs
        2. Cats
        3. Horses
        4. Others
      2. By Route of Administration
        1. Oral
        2. Injectable
        3. Topical
      3. By Product
        1. Antibiotics
        2. Anti-inflammatory
        3. Parasiticides
        4. Vaccines
        5. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Companion Animal Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Animal
      2. By Route of Administration
      3. By Product
      4. By Country
        1. United States
          1. By Animal
          2. By Route of Administration
          3. By Product
        2. Canada
          1. By Animal
          2. By Route of Administration
          3. By Product
  6. Europe Companion Animal Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Animal
      2. By Route of Administration
      3. By Product
      4. By Country
        1. Germany
          1. By Animal
          2. By Route of Administration
          3. By Product
        2. United Kingdom
          1. By Animal  
          2. By Route of Administration
          3. By Product
        3. Italy
          1. By Animal
          2. By Route of Administration
          3. By Product
        4. France
          1. By Animal
          2. By Route of Administration
          3. By Product
        5. Spain
          1. By Animal
          2. By Route of Administration
          3. By Product
        6. Belgium
          1. By Animal
          2. By Route of Administration
          3. By Product
        7. Russia
          1. By Animal
          2. By Route of Administration
          3. By Product
        8. The Netherlands
          1. By Animal
          2. By Route of Administration
          3. By Product
        9. Rest of Europe
          1. By Animal  
          2. By Route of Administration
          3. By Product
  7. Asia-Pacific Companion Animal Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Animal
      2. By Route of Administration
      3. By Product
      4. By Country
        1. China
          1. By Animal
          2. By Route of Administration
          3. By Product
        2. India
          1. By Animal  
          2. By Route of Administration
          3. By Product
        3. Japan
          1. By Animal
          2. By Route of Administration
          3. By Product
        4. South Korea
          1. By Animal
          2. By Route of Administration
          3. By Product
        5. Australia & New Zealand
          1. By Animal
          2. By Route of Administration
          3. By Product
        6. Indonesia
          1. By Animal
          2. By Route of Administration
          3. By Product
        7. Malaysia
          1. By Animal
          2. By Route of Administration
          3. By Product
        8. Singapore
          1. By Animal
          2. By Route of Administration
          3. By Product
        9. Vietnam
          1. By Animal
          2. By Route of Administration
          3. By Product
        10. Rest of APAC
          1. By Animal
          2. By Route of Administration
          3. By Product
  8. Latin America Companion Animal Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Animal
      2. By Route of Administration
      3. By Product
      4. By Country
        1. Brazil
          1. By Animal
          2. By Route of Administration
          3. By Product
        2. Mexico
          1. By Animal
          2. By Route of Administration
          3. By Product
        3. Argentina
          1. By Animal
          2. By Route of Administration
          3. By Product
        4. Peru
          1. By Animal
          2. By Route of Administration
          3. By Product
        5. Rest of LATAM
          1. By Animal
          2. By Route of Administration
          3. By Product
  9. Middle East & Africa Companion Animal Pharmaceuticals Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Animal
      2. By Route of Administration
      3. By Product
      4. By Country
        1. Saudi Arabia
          1. By Animal
          2. By Route of Administration
          3. By Product
        2. UAE
          1. By Animal
          2. By Route of Administration
          3. By Product
        3. Qatar
          1. By Animal
          2. By Route of Administration
          3. By Product
        4. Kuwait
          1. By Animal
          2. By Route of Administration
          3. By Product
        5. South Africa
          1. By Animal
          2. By Route of Administration
          3. By Product
        6. Nigeria
          1. By Animal
          2. By Route of Administration
          3. By Product
        7. Algeria
          1. By Animal
          2. By Route of Administration
          3. By Product
        8. Rest of MEA
          1. By Animal
          2. By Route of Administration
          3. By Product
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Companion Animal Pharmaceuticals Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Companion Animal Pharmaceuticals Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Zoetis Inc.
    2. Merck Animal Health
    3. Boehringer Ingelheim International GmbH
    4. Elanco Animal Health Incorporated
    5. Bayer AG
    6. Virbac
    7. Dechra Pharmaceuticals PLC
    8. Vetoquinol SA
    9. Ceva Santé Animale
    10. Kindred Biosciences, Inc.
    11. Norbrook
    12. IDEXX Laboratories, Inc.
    13. Animalcare Group plc
    14. Neogen Corporation
    15. Heska Corporation
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

Figure 1       Global Companion Animal Pharmaceuticals Market Segmentation

Figure 2       Global Companion Animal Pharmaceuticals Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 6       Global Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 7       Global Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 8       Global Companion Animal Pharmaceuticals Market Share, By Region, By Value, 2019–2029

Figure 9       North America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 10     North America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 11     North America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 12     North America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 13     North America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Figure 14     United States Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 15     United States Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 16     United States Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 17     United States Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 18     Canada Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 19     Canada Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 20     Canada Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 21     Canada Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 22     Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 23     Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 24     Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 25     Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 26     Europe Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Figure 27     Germany Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 28     Germany Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 29     Germany Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 30     Germany Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 31     United Kingdom Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 32     United Kingdom Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 33     United Kingdom Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 34     United Kingdom Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 35     Italy Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 36     Italy Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 37     Italy Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 38     Italy Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 39     France Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 40     France Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 41     France Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 42     France Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 43     Spain Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 44     Spain Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 45     Spain Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 46     Spain Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 47     Belgium Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 48     Belgium Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 49     Belgium Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 50     Belgium Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 51     Russia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 52     Russia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 53     Russia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 54     Russia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 55     The Netherlands Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 56     The Netherlands Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 57     The Netherlands Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 58     The Netherlands Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 59     Rest of Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 60     Rest of Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 61     Rest of Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 62     Rest of Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 63     Asia-Pacific Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 64     Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 65     Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 66     Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 67     Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Figure 68     China Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 69     China Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 70     China Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 71     China Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 72     India Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 73     India Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 74     India Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 75     India Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 76     Japan Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 77     Japan Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 78     Japan Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 79     Japan Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 80     South Korea Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 81     South Korea Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 82     South Korea Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 83     South Korea Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 84     Australia & New Zealand Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 85     Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 86     Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 87     Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 88     Indonesia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 89     Indonesia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 90     Indonesia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 91     Indonesia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 92     Malaysia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 93     Malaysia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 94     Malaysia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 95     Malaysia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 96     Singapore Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 97     Singapore Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 98     Singapore Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 99     Singapore Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 100   Vietnam Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 101   Vietnam Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 102   Vietnam Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 103   Vietnam Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 104   Rest of APAC Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 105   Rest of APAC Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 106   Rest of APAC Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 107   Rest of APAC Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 108   Latin America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 109   Latin America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 110   Latin America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 111   Latin America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 112   Latin America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Figure 113   Brazil Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 114   Brazil Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 115   Brazil Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 116   Brazil Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 117   Mexico Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 118   Mexico Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 119   Mexico Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 120   Mexico Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 121   Argentina Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 122   Argentina Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 123   Argentina Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 124   Argentina Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 125   Peru Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 126   Peru Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 127   Peru Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 128   Peru Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 129   Rest of LATAM Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 130   Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 131   Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 132   Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 133   Middle East & Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 134   Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 135   Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 136   Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 137   Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Figure 138   Saudi Arabia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 139   Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 140   Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 141   Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 142   UAE Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 143   UAE Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 144   UAE Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 145   UAE Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 146   Qatar Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 147   Qatar Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 148   Qatar Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 149   Qatar Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 150   Kuwait Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 151   Kuwait Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 152   Kuwait Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 153   Kuwait Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 154   South Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 155   South Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 156   South Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 157   South Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 158   Nigeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 159   Nigeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 160   Nigeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 161   Nigeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 162   Algeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 163   Algeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 164   Algeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 165   Algeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Figure 166   Rest of MEA Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Figure 167   Rest of MEA Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Figure 168   Rest of MEA Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Figure 169   Rest of MEA Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

 

List of Tables

 

Table 1 Global Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 2 Global Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 3 Global Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 4 Global Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 5 Global Companion Animal Pharmaceuticals Market Share, By Region, By Value, 2019–2029

Table 6 North America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 7 North America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 8 North America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 9 North America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 10      North America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Table 11      United States Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 12      United States Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 13      United States Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 14      United States Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 15      Canada Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 16      Canada Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 17      Canada Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 18      Canada Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 19      Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 20      Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 21      Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 22      Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 23      Europe Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Table 24      Germany Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 25      Germany Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 26      Germany Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 27      Germany Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 28      United Kingdom Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 29      United Kingdom Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 30      United Kingdom Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 31      United Kingdom Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 32      Italy Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 33      Italy Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 34      Italy Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 35      Italy Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 36      France Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 37      France Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 38      France Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 39      France Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 40      Spain Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 41      Spain Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 42      Spain Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 43      Spain Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 44      Belgium Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 45      Belgium Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 46      Belgium Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 47      Belgium Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 48      Russia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 49      Russia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 50      Russia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 51      Russia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 52      The Netherlands Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 53      The Netherlands Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 54      The Netherlands Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 55      The Netherlands Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 56      Rest of Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 57      Rest of Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 58      Rest of Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 59      Rest of Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 60      Asia-Pacific Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 61      Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 62      Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 63      Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 64      Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Table 65      China Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 66      China Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 67      China Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 68      China Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 69      India Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 70      India Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 71      India Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 72      India Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 73      Japan Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 74      Japan Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 75      Japan Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 76      Japan Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 77      South Korea Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 78      South Korea Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 79      South Korea Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 80      South Korea Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 81      Australia & New Zealand Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 82      Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 83      Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 84      Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 85      Indonesia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 86      Indonesia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 87      Indonesia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 88      Indonesia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 89      Malaysia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 90      Malaysia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 91      Malaysia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 92      Malaysia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 93      Singapore Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 94      Singapore Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 95      Singapore Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 96      Singapore Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 97      Vietnam Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 98      Vietnam Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 99      Vietnam Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 100    Vietnam Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 101    Rest of APAC Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 102    Rest of APAC Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 103    Rest of APAC Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 104    Rest of APAC Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 105    Latin America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 106    Latin America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 107    Latin America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 108    Latin America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 109    Latin America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Table 110    Brazil Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 111    Brazil Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 112    Brazil Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 113    Brazil Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 114    Mexico Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 115    Mexico Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 116    Mexico Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 117    Mexico Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 118    Argentina Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 119    Argentina Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 120    Argentina Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 121    Argentina Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 122    Peru Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 123    Peru Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 124    Peru Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 125    Peru Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 126    Rest of LATAM Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 127    Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 128    Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 129    Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 130    Middle East & Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 131    Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 132    Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 133    Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 134    Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029

Table 135    Saudi Arabia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 136    Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 137    Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 138    Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 139    UAE Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 140    UAE Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 141    UAE Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 142    UAE Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 143    Qatar Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 144    Qatar Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 145    Qatar Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 146    Qatar Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 147    Kuwait Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 148    Kuwait Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 149    Kuwait Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 150    Kuwait Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 151    South Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 152    South Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 153    South Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 154    South Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 155    Nigeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 156    Nigeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 157    Nigeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 158    Nigeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 159    Algeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 160    Algeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 161    Algeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 162    Algeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 163    Rest of MEA Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029

Table 164    Rest of MEA Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029

Table 165    Rest of MEA Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029

Table 166    Rest of MEA Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029

Table 167    Zoetis Inc.   Company Overview

Table 168    Zoetis Inc.   Financial Overview

Table 169    Merck Animal Health        Company Overview

Table 170    Merck Animal Health        Financial Overview

Table 171    Boehringer Ingelheim International GmbH     Company Overview

Table 172    Boehringer Ingelheim International GmbH     Financial Overview

Table 173    Elanco Animal Health Incorporated      Company Overview

Table 174    Elanco Animal Health Incorporated      Financial Overview

Table 175    Bayer AG     Company Overview

Table 176    Bayer AG     Financial Overview

Table 177    Virbac Company Overview

Table 178    Virbac Financial Overview

Table 179    Dechra Pharmaceuticals PLC      Company Overview

Table 180    Dechra Pharmaceuticals PLC      Financial Overview

Table 181    Vetoquinol SA        Company Overview

Table 182    Vetoquinol SA        Financial Overview

Table 183    Ceva Santé Animale         Company Overview

Table 184    Ceva Santé Animale         Financial Overview

Table 185    Kindred Biosciences, Inc. Company Overview

Table 186    Kindred Biosciences, Inc. Financial Overview

Table 187    Norbrook      Company Overview

Table 188    Norbrook      Financial Overview

Table 189    IDEXX Laboratories, Inc.  Company Overview

Table 190    IDEXX Laboratories, Inc.  Financial Overview

Table 191    Animalcare Group plc       Company Overview

Table 192    Animalcare Group plc       Financial Overview

Table 193    Neogen Corporation         Company Overview

Table 194    Neogen Corporation         Financial Overview

Table 195    Heska Corporation Company Overview

Table 196    Heska Corporation Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major factors driving the growth of the Global Companion Animal Pharmaceuticals Market include growing pet ownership and increasing humanization of pets, rising awareness about animal health and wellness, and increasing advancements in veterinary healthcare technology.
Ans: Global Companion Animal Pharmaceuticals Market size was estimated at USD 34.8 billion in 2022.
Ans: The dogs segment is expected to hold the highest market share in the Global Companion Animal Pharmaceuticals Market by animal.
Ans: The parasiticides segment is expected to hold the highest market share in the Global Companion Animal Pharmaceuticals Market by product.
Ans: Key players in the Global Companion Animal Pharmaceuticals Market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Bayer AG, Virbac, Dechra Pharmaceuticals PLC, Vetoquinol SA, Ceva Santé Animale, Kindred Biosciences, Inc., Norbrook, IDEXX Laboratories, Inc., Animalcare Group plc, Neogen Corporation, and Heska Corporation.